Amneal Pharmaceuticals, Inc.
- Stock
- Ticker AMRX
- ISIN US03168L1052
- Nasdaq
Performance, volatility and drawdowns of Amneal Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $14,821. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −94.8% in 03/2023, measured from the peak in 08/2018. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 731 | 695 | 725 | 785 | 814 | 723 | 796 | 863 |
| Gross profit | 263 | 256 | 286 | 274 | 297 | 320 | 335 | 334 |
| Operating income | 76 | 100 | 111 | 70 | 112 | 142 | 130 | 95 |
| EBITDA | – | – | – | 85 | 126 | – | – | 110 |
| Net income | -31 | 12 | 22 | 2.4 | 35 | 62 | 58 | -22 |
| Earnings per share | -0.10 | 0.04 | 0.07 | 0.01 | 0.11 | 0.19 | 0.18 | -0.06 |
| Balance sheet | ||||||||
| Total assets | 3,501 | 3,365 | 3,423 | 3,600 | 3,678 | 3,540 | 3,776 | 5,267 |
| Liabilities | 3,611 | 3,497 | 3,535 | 3,710 | 3,750 | 3,586 | 3,743 | 4,736 |
| Equity | -109 | -132 | -112 | -109 | -71 | -45 | 33 | 531 |
| Cash | 111 | 59 | 72 | 201 | 282 | 198 | 128 | 157 |
| Long-term debt | 2,162 | 2,154 | 2,146 | 2,567 | 2,565 | 2,566 | 2,564 | 2,916 |
| Cash flow | ||||||||
| Operating cash flow | 118 | 7.4 | 84 | 118 | 130 | -27 | -21 | 98 |
| Capital expenditure | -15 | -13 | -23 | -12 | -22 | -8.2 | -31 | -32 |
| Free cash flow | 103 | -5.8 | 61 | 106 | 109 | -35 | -52 | 67 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2023 at +205.0%, weakest 2019 at −64.4%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$0.06 |
| 6 Aug 2026 | $0.18 |
| 7 May 2026 | $0.19 |
| 27 Feb 2026 | $0.11 |
| 6 Nov 2025 | $0.01 |
| 7 Aug 2025 | $0.07 |
| 7 May 2025 | $0.04 |
| 28 Feb 2025 | −$0.10 |
| 12 Nov 2024 | $0.00 |
| 9 Aug 2024 | $0.02 |
| 8 May 2024 | −$0.30 |
| 14 Mar 2024 | −$0.57 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €6.7bn
- Market cap in trading currency
- $7.36bn
- Enterprise value
- $10.1bn
- P/E
- 50.3
- P/S
- 2.30
- P/B
- 13.85
- EV/Sales
- 3.17
- EV/EBITDA
- –
- Earnings yield
- 2.0%
- FCF yield
- 1.2%
Results (last four quarters)
- Revenue
- $3.20bn
- Gross profit
- $1.29bn
- EBITDA
- –
- Net income
- $133m
- Earnings per share
- $0.42
- Revenue per share
- $9.17
- Revenue growth
- +10.0%
- Earnings growth
- −1,015.8%
Profitability
- Gross margin
- 40.2%
- Operating margin
- 15.0%
- Net margin
- 4.2%
- Return on equity
- 25.1%
- Return on assets
- 2.5%
Balance sheet and cash flow
- Cash
- $157m
- Cash per share
- $0.45
- Financial debt
- $2.94bn
- Debt/equity %
- 553
- Current ratio
- 1.87
- Book value per share
- $1.52
- Operating cash flow
- $181m
- Free cash flow
- $88.2m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 348m
- Volume
- 1.66m
- Avg. volume 3 months
- 3.16m
- Relative volume
- 0.5
Price and technicals
- Price
- $21.12
- 1 day
- −1.3%
- 52-week high
- $21.88
- 52-week low
- $11.52
- Distance to 52-week high
- −3.5%
- Distance to 52-week low
- +83.4%
- Distance to 50-day line
- +4.9%
- Distance to 200-day line
- +29.8%
- RSI (14)
- 54
- Volatility 1M
- 38.8%
Performance
- 1 week
- −1.2%
- 1 month
- +3.1%
- 3 months
- +18.8%
- 6 months
- +70.0%
- YTD
- +67.6%
- 1 year
- +83.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has AMRX performed since 11/2016?
$10,000 grew to $14,821 by 20 Nov 2026, which is +4.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is AMRX?
Volatility was 52.8% per year, measured on monthly returns. The largest decline from a peak was −94.8%, with the low in 03/2023.
How does AMRX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, AMRX returned +4.0% at 52.8%. The correlation of monthly returns was 0.37; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.